RxDoctor Payments Data

Elizabeth Katz, MD

Otolaryngology · Athens, GANPI 1780844639

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $358, 2.4 times the $147 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in GA, where the typical reported total is $1,278.

$1,357in general payments, 2019–2025

Across 56 payments — averaging $24.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$254
  • Inspire Medical Systems, Inc.$181
  • Kaleo, Inc.$175
  • Medtronic$131
  • Sanofi$111
  • Optinose US, Inc.$105
  • plus $400 from 11 others

What the payments were for

  • Food & beverage$1,357100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,357 in reported general payments places this provider in the 50th percentile of 308 otolaryngology providers in Georgia.

See all otolaryngology providers in Georgia →

Medicare billing

Part B allowed, 2024
$103,905
Medicare patients
330
Services billed
1,852

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab13$48,589
Ipratropium Bromide69$3,240
Epinephrine14$2,140
Fluticasone Propionate99$1,839
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,021
Fluconazole34$947
Azelastine Hcl35$734
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav40$612
Levocetirizine Dihydrochloride22$376
Ondansetron OdtOndansetron28$254
Omeprazole11$221
Ofloxacin14$158
Doxycycline Hyclate15$129
Montelukast Sodium12$122
Famotidine23$102

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Athens

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →